Norwegian Coronavirus Disease 2019 Study
NCT04316377
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
53
Enrollment
OTHER
Sponsor class
Conditions
Corona Virus Infection
Interventions
DRUG:
Hydroxychloroquine Sulfate
Sponsor
University Hospital, Akershus